Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Mar 26, 2015; 7(3): 150-156
Published online Mar 26, 2015. doi: 10.4330/wjc.v7.i3.150
Published online Mar 26, 2015. doi: 10.4330/wjc.v7.i3.150
Percutaneous closure of secundum type atrial septal defects: More than 5-year follow-up
Roel JR Snijder, Maarten J Suttorp, Jurriën M Ten Berg, Martijn C Post, Department of Cardiology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands
Author contributions: Snijder RJ, Suttorp MJ, Ten Berg JM and Post MC had substantial contributions to conception and design, acquisition of data, analysis and interpretation of data; Snijder RJ drafted the article; Suttorp MJ, Ten Berg JM and Post MC revised the article critically for important intellectual content; all authors gave final approval for publication.
Ethics approval: United Committee for Human Bound Research approval code: V.32916/W14.082/sw/mk.
Informed consent: All patients provided informed oral consent. Further, our institutional review board approved our study and stated that no informed written consent was necessary.
Conflict-of-interest: None of the authors had a conflict of interest.
Data sharing: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Martijn C Post, MD, PhD, Department of Cardiology, St. Antonius Hospital, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands. m.post@antoniusziekenhuis.nl
Telephone: +31-88-3203000 Fax: +31-30-6034420
Received: October 28, 2014
Peer-review started: October 29, 2014
First decision: November 27, 2014
Revised: January 14, 2015
Accepted: January 30, 2015
Article in press: February 2, 2015
Published online: March 26, 2015
Peer-review started: October 29, 2014
First decision: November 27, 2014
Revised: January 14, 2015
Accepted: January 30, 2015
Article in press: February 2, 2015
Published online: March 26, 2015
Core Tip
Core tip: Several atrial septal defect (ASD) closing devices have been proven safe and effective for percutaneous ASD closure. We evaluated long-term (i.e., more than 5-year of follow-up) efficacy of two different devices used in adults. Percutaneous ASD closure seems to be relatively safe using the Amplatzer device. Though, the right-to-left shunt (RLS) rate is high, a residual left-to-right shunt was absent at latest follow up. The Cardioseal/Starflex device appears to be associated with a higher complication- and residual RLS rate. The importance of a residual RLS is unclear. Therefore, long-term follow up might be necessary.